Currently Viewing:
Patient-Centered Oncology Care
Dr Mark Fleury Highlights ACS CAN's Advocacy Efforts
June 11, 2018
Dr Mark Fleury Highlights ACS CAN's Involvement in the FDA's Patient-Focused Drug Development Initiative
June 02, 2018
Ian Manners Outlines Pharma's Participation in Providing Financial Assistance for Patients
May 23, 2018
Dr Mark Fleury on 21st Century Cures and Cancer Care
May 21, 2018
Ian Manners Explains How Vivor Empowers Providers and Financial Navigators
May 03, 2018
Dr Thomas Graf: Personalizing Cancer Care Payment Models
April 16, 2018
Dr Stacey McCullough Discusses Teamwork and Collaboration in Oncology
April 13, 2018
Torrie Fields: Collecting and Using Data Can Better Inform a Patient
April 12, 2018
Dr Thomas Graf Discusses the Effect of Novel Therapies on Private Coverage
April 06, 2018
Kathleen Lokay: Incorporating the Latest Research and Supporting Physicians
April 05, 2018
Dr Stacey McCullough on the Pharmacist's Role in Patient Education
March 29, 2018
Dr Thomas Graf: How the Impact of Novel Therapies Varies Among Stakeholders
March 22, 2018
Jason Harris Highlights National Health Council's Recommendations on Real-World Evidence
March 18, 2018
Ian Manners Explains the Impact of Patient Financial Assistance Programs
March 17, 2018
Dr Thomas Graf on the Impact of New Therapies in Oncology
March 12, 2018
Jason Harris: Improving Patient Understanding and Promoting High-Value Care
March 02, 2018
Dr Brenton Fargnoli on Fixing Issues Physicians Have With EHRs
February 18, 2018
Kathleen Lokay: Implementing Value in Clinical Pathways
February 13, 2018
Jason Harris Discusses the Importance of Real-World Evidence
February 11, 2018
Dr Brenton Fargnoli Explains How Quality Measurement Benchmarks Drive Action
February 09, 2018
Currently Reading
Kathleen Lokay on Educating Patients on Treatment Options
January 28, 2018
Kathleen Lokay on How Data Generation Informs Clinical Pathways
January 16, 2018
Torrie Fields: Data Collection Takes the Guesswork Out of Care
January 01, 2018
Kathleen Lokay: Clinical Pathways Can Prevent Prior Authorization Delays
December 24, 2017

Kathleen Lokay on Educating Patients on Treatment Options

Kathleen Lokay, president and CEO of Via Oncology, encourages physicians to educate patients on clinical pathways and discusses how the patient voice is heard.

Kathleen Lokay, president and CEO of Via Oncology, encourages physicians to educate patients on clinical pathways and discusses how the patient voice is heard.


Do you have patients involved in the pathways program process to include patient preferences?

Not so much in the sense that we don’t really have patient-facing tools, but what we do provide to our customers is patient education around the drugs to help the patients understand the risk versus benefits of the regiment. But the patient’s voice is really brought to the table through the physicians.

We don’t actually have patients on our committees and it’s not that we are opposed to that it’s just that the committees are very, very scientific. We have reached out and engaged many of the patient advocacy foundations to really try to have them be partners in understanding how we go about representing the patient voice. Ultimately, it’s up to the physician, and we would encourage physicians when talking to patients share the pathway with them, let them see why the pathway recommends this or that and even discuss with them maybe why that patient doesn’t fit the pathway and therefore, should be off pathway. That’s certainly something every physician should do anytime they are meeting with their patient and discussing treatment decisions.

Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome the the new and improved, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up

Sign In

Not a member? Sign up now!